Huntington Kelly Michelle sold $915K of MYRG

Huntington Kelly Michelle (Senior VP and CFO) sold 2,000 shares of MYR GROUP INC. (MYRG) at an average of $457.66 ($453.20–$460.03, $0.92M total) across 5 trades on 2026-06-01.

Original reporting
SEC EDGAR · Huntington Kelly Michelle
Published Jun 2, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 3:50 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MYRG
Bearish
medium confidence
Mentioned
$MYRG
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MYRGBearishLow
01

Why it matters

The $915K sale reduces insider ownership, which may be interpreted as a bearish cue.

02

Market read

The filing provides fresh, primary‑source data on insider activity, offering a modest trading cue.

03

What to watch

No 10b5‑1 plan was used; the CFO may be diversifying personal holdings.

Relevance 5/10Novelty 4/10Timing: after-hours filing

Background

Form 4 filings disclose insider transactions; a senior officer's sale is noteworthy for traders.

Company-level read

Ticker impact

$MYRGBearishMedium confidence
Context

CFO Huntington Kelly Michelle sold 2,000 shares for $915K, reducing her stake to 4,691 shares.

Expected impact

potential downward pressure as market absorbs the insider sale

Evidence & confidence

The sale is sizable for a micro‑cap and comes from a senior officer, which can prompt short‑term selling.

Market effects

Minimal impact on the broader biotech sector.

Limited to U.S. over‑the‑counter investors in MYRG.

Low

Counterpoint

The sale could be a routine portfolio rebalancing rather than a negative signal.

Key entities

  • Huntington Kelly Michelle

    Senior VP and CFO of MYR Group Inc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MYRGMed

KeyBanc upgrades MYR Group stock rating on balanced portfolio

KeyBanc upgraded MYR Group (NASDAQ:MYRG) to Overweight with a $361 price target, citing its balanced portfolio and strong fundamentals. The stock is down 44% in six months but is considered undervalued. MYR Group reported Q3 2026 earnings of $3.82 per share on $1.26B revenue, beating estimates, with a 38% increase in backlog to $3.68B. Revenue grew 32% YoY, driven by strong demand in commercial, industrial, and transmission sectors.

$MYRGMedAI 9/10

MYR Group (MYRG) Q3 2026 Earnings Call Transcript

MYR Group (MYRG) reported Q3 2026 record revenues of $1.26B, up 32% YoY, with T&D and C&I segments growing 10% and 58% respectively. Net income rose 86% to $60M, while backlog reached $3.68B. The company attributed growth to acquisitions and market demand, and announced a $100M share repurchase program.

$MYRGMedAI 8/10

What MYR Group (MYRG) Said on Its Q3 Earnings Call

MYR Group (MYRG) reported Q3 revenue of $555M, up 10%, with gross margin expanding to 13.6%. Operating margins improved in both segments. Backlog reached a record $3.68B. Management expects 18-22% C&I revenue growth and 10-13% T&D growth next year. The company has $650M borrowing availability and a new $100M share buyback program.

$MYRGHighAI 8/10

MYR Group gains on strong earnings and revenue beat

MYR Group Inc (MYRG) reported Q3 earnings of $3.82 per share, beating estimates by $0.83, with revenue of $1.26B, up 32% YoY. Shares rose 10% in after-hours trading. Net income increased to $60M from $32.1M YoY. The company's backlog grew 38.2% to $3.68B. MYR's board approved a $100M share repurchase program.